Conroy

Hologic to Acquire Third Wave Technologies

...the transaction is completed, and to participating in the launch of Third Wave's existing and future product lines. "We have great respect for Kevin conroy and his team, the exciting products they have developed and the expertise they bring to Hologic. Before offering to acquire Third Wave, we conducted e...

Lack of training for children's medicines prescribing may increase risk of error

...here is no validated method of assessment, and no national standards, say the authors, led by Dr Sharon Conroy, of The University of Nottingham. Dr conroy and colleagues acknowledge that their research may not reflect a comprehensive picture of training for prescribing, but suggest that at the very least...

Alcohol Consumption Could Lead to Disturbed Sleep

... reported the online edition of science portal EurekAlert. Deirdre A. conroy and other researchers at the University of Michigan examined 18 people - ni...ality sleep at night, they might be more vulnerable to return to drinking," conroy said. The researchers will next examine if sleep problems can be attri...

Alcohol Dependence For Sleep Perceptions May Result In Alcoholism

... Deirdre A. conroy conducted a new study about alcoholism and published the results in the December issue of Alcoholism: Clinical & Experimental Research.// The study h...

Meat firm 'won't go down without a fight'

... real estate holdings. Conroy's Small goods joint managing director Pat conroy said the company had lost about $10,000 a day since its forced shutdown in ...floor drains and cryovac machine. It has since removed the conveyor. Mr conroy said independent tests on machinery last Friday had been bacteria-free. He ...

Conroy in Biological News

UGA study may give hope that ivory-billed woodpeckers still around

...rofessor Michael Conroy. "It just shows that they could have persisted." conroy is one of several scientists on the team who conducted a population viabili...analysis shows that the probability is larger than originally suspected. conroy is optimistic about implications from their findings for similar species th...

Dust in West up 500 percent in past 2 centuries, says CU-Boulder study

...rs included CU-Boulder's Ashley Ballantyne, Lang Farmer and Corey Lawrence, Cornell University's Natalie Mahowald, the University of Arizona's Jessica conroy and Jonathan Overpeck, Christopher Landry of the Center of Snow and Avalanche Studies in Silverton, Colo., the University of Utah's Tom Painter and th...

Conroy in Biological Technology

Third Wave CEO steps aside as company departs research market

... Madison, Wis. At Third Wave Technologies, former vice president Kevin conroy is stepping into the shoes of president and CEO. John Puisis, who was CEO s...t remains to be seen what the close of 2005 will bring for the company, but conroy will have his plate full in 2006. Conroy, who is 40 and comes from a leg...

Third Wave licenses Innogenetics tech to settle lawsuit

...an market. In a press release about the settlement, Third Wave CEO Kevin conroy said it "will help to accelerate the global growth of our molecular diagnostics business and further build shareholder value." conroy was the firm's general counsel when the suit was filed. "With leading di...

Third Wave posts $22 million loss, stock rises

...ng clinical customer base to more than 140, and launched new clinical products, including our FDA-cleared UGT1A1 pharmacogenetic test," said CEO Kevin conroy in a press release. "Our Invader chemistry also enables us to capture recurring-revenue opportunities in the research and agricultural markets and we ...

Third Wave's revenues rebound

...ill fiercely defend the basic Invader technology," conroy said. Lai said the lawsuits have done nothing ...d, particularly in the human papillomavirus (HPV). conroy said that HPV diagnosis and treatment forms a mark...rything we can to be a major part of that market," conroy said, adding that Third Wave will announce its pro...

Third Wave reports net loss of $18.9M for 2006

...cts and an application to the Food and Drug Administration for approval of a cystic fibrosis molecular test. President and chief executive Kevin conroy said the expense of HPV clinical trials and other litigation will cause operating expenses to increase in 2007. ...